VEGFA and colorectal carcinoma: Angiogenesis is mandatory for a tumor to grow, which is why drugs neutralizing vascular endothelial growth factor (VEGF), e.g., bevacizumab, have become part of the treatment of metastasizing CRC (mCRC).